Irish biopharma group Alkermes has reported record revenues for 2013 and forecast a strong year ahead for drugs at an a(...)
When Alkermes acquired Elan’s drug technology business in Athlone in a $960 million buyout two years ago, everyone knew what it was after – or at leas(...)
Irish biopharma business Alkermes yesterday hosted a gathering of US investors in their only Irish stop on the European tour.The group of investment f(...)
Alkermes, the company that acquired Elan Drug Technologies, yesterday reported “robust” results for what it called a “remarkable year”.
Alkermes, the US company that acquired Elan’s drug manufacturing business in Athlone, announced today that it will cut almost a third of the wo(...)
Browse by Publication Date